Suppr超能文献

猫传染性腹膜炎 (FIP) 和新型冠状病毒病 19 (COVID-19):它们相似吗?

Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID-19): Are they similar?

机构信息

Department of Veterinary Medicine, University of Milan, Lodi, Italy.

Veterinary Teaching Hospital, University of Milan, Lodi, Italy.

出版信息

Transbound Emerg Dis. 2021 Jul;68(4):1786-1799. doi: 10.1111/tbed.13856. Epub 2020 Oct 20.

Abstract

SARS-CoV-2 has radically changed our lives causing hundreds of thousands of victims worldwide and influencing our lifestyle and habits. Feline infectious peritonitis (FIP) is a disease of felids caused by the feline coronaviruses (FCoV). FIP has been considered irremediably deadly until the last few years. Being one of the numerous coronaviruses that are well known in veterinary medicine, information on FCoV could be of interest and might give suggestions on pathogenic aspects of SARS-CoV-2 that are still unclear. The authors of this paper describe the most important aspects of FIP and COVID-19 and the similarities and differences between these important diseases. SARS-CoV-2 and FCoV are taxonomically distant viruses, and recombination events with other coronaviruses have been reported for FCoV and have been suggested for SARS-CoV-2. SARS-CoV-2 and FCoV differ in terms of some pathogenic, clinical and pathological features. However, some of the pathogenic and immunopathogenic events that are well known in cats FIP seem to be present also in people with COVID-19. Moreover, preventive measures currently recommended to prevent SARS-CoV-2 spreading have been shown to allow eradication of FIP in feline households. Finally, one of the most promising therapeutic compounds against FIP, GS-441524, is the active form of Remdesivir, which is being used as one therapeutic option for COVID-19.

摘要

SARS-CoV-2 彻底改变了我们的生活,在全球范围内造成数十万人死亡,并影响了我们的生活方式和习惯。猫传染性腹膜炎(FIP)是一种由猫冠状病毒(FCoV)引起的猫科动物疾病。直到最近几年,FIP 一直被认为是无法治愈的致命疾病。作为兽医界众多知名冠状病毒之一,关于 FCoV 的信息可能会引起人们的兴趣,并可能对 SARS-CoV-2 的发病机制方面提供一些启示,这些方面目前仍不清楚。本文作者描述了 FIP 和 COVID-19 的最重要方面,以及这两种重要疾病之间的相似之处和不同之处。SARS-CoV-2 和 FCoV 是分类学上相距较远的病毒,已经报道了 FCoV 与其他冠状病毒的重组事件,并推测 SARS-CoV-2 也存在这种情况。SARS-CoV-2 和 FCoV 在一些发病机制、临床和病理特征方面存在差异。然而,在猫 FIP 中已知的一些发病机制和免疫发病机制事件似乎也存在于 COVID-19 患者中。此外,目前推荐的预防 SARS-CoV-2 传播的措施已被证明可以在猫科动物家庭中消除 FIP。最后,针对 FIP 的最有前途的治疗化合物之一 GS-441524 是瑞德西韦的活性形式,瑞德西韦正在被用作 COVID-19 的一种治疗选择。

相似文献

引用本文的文献

2
Assessment for Risk of Possible Human Transmission of FCoV-23.评估猫冠状病毒23型可能发生人际传播的风险。
Transbound Emerg Dis. 2024 Oct 1;2024:8398470. doi: 10.1155/2024/8398470. eCollection 2024.
4
A review of feline infectious peritonitis virus infection.猫传染性腹膜炎病毒感染综述
Vet World. 2024 Nov;17(11):2417-2432. doi: 10.14202/vetworld.2024.2417-2432. Epub 2024 Nov 5.

本文引用的文献

4
Timelines of COVID-19 vaccines.新冠疫苗的时间线。
Curr Med Res Pract. 2020 Jul-Aug;10(4):137-138. doi: 10.1016/j.cmrp.2020.07.009. Epub 2020 Jul 21.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验